Basel Medical Group Ltd
BMGL
$0.80
-$0.05-6.27%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.73% | -3,571.15% | 1.08% | -143.60% | -0.97% |
| Total Depreciation and Amortization | 3.70% | 133.46% | -1.13% | 36.86% | -0.92% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.73% | 3,956.99% | 1.04% | -2.02% | 0.95% |
| Change in Net Operating Assets | 3.75% | 113.73% | 1.09% | -327.63% | -0.97% |
| Cash from Operations | -3.70% | 85.55% | 1.09% | -264.50% | -0.97% |
| Capital Expenditure | -3.73% | -59,140.58% | 1.43% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3.47% | -199.02% | -0.97% | -- | -- |
| Cash from Investing | -3.72% | -30,528.15% | -0.74% | -- | -- |
| Total Debt Issued | 0.00% | 138.20% | 0.00% | 357.88% | 0.00% |
| Total Debt Repaid | 0.00% | 27.26% | 0.00% | -297.01% | 0.00% |
| Issuance of Common Stock | 0.00% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | -184.79% | 0.00% | 1,168.98% | 0.00% |
| Cash from Financing | 3.73% | -18.36% | -1.09% | 800.06% | 0.97% |
| Foreign Exchange rate Adjustments | -3.74% | -3,884.44% | 2.17% | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.72% | -180.36% | -1.09% | 459.86% | -0.96% |